 |
New Mountain Capital has spun off Swoop, provider of precision AI-driven healthcare omnichannel solutions, from Real Chemistry.
Swoop operated as a unit of Real Chemistry, which ranks as O’Dwyer’s top ranked healthcare shop, for the past four years.
Its offerings help drug and life sciences brands find, target and engage with their patient and provider audiences.
Ron Elwell, founder/CEO of Swoop, sees the spin-off as a way to execute on an even more expansive shared vision for the business.
He said Swoop will hyper-focus on driving privacy-safe innovation and guide clients as they reimagine how to engage with stakeholders in a data-driven, personalized and digital manner.
Real Chemistry and Swoop will maintain a preferred partnership arrangement.
Swoop has also partnered with Ogilvy Health, Saatchi & Saatchi, FCBHealth, Klick Health, Digital, Evoke, Wunderman Thompson and McCann Health.
H/Advisors Abernathy’s Dana Gorman represents New Mountain Capital, the New York investment firm.
Havas owns H/Advisors.
Public Policy Holding Company registered 23.8 percent Q3 growth to $48.8M, with organic growth contributing 4.5 percent and the balance driven by merger & acquisition activity.
Publicis Groupe reported 3.1 percent in Q3 growth to $4B, sparked by a 3.6 percent jump North America, its biggest market.
WPP suffered a 10.2 percent drop in 1H revenues to $6.7B and a 47.8 percent plunge in operating profit to $297M.
Interpublic reported Q2 net revenues dropped 6.6 percent to $2.2B and operating income tumbled 23.4 percent to $243.7M. 
WPP has adopted a gloomier profit and sales forecast due to a deteriorating Q2 financial performance triggered by weak client spending as companies cope with the challenging economic backdrop.
